Intragenic mutations of the p16INK4, p15INK4B and p18 GENES in primary non-small-cell lung cancers

International Journal of Cancer

Volumn 65, Issue 6, 1996, Pages 734-739

  Rusin, Marek R ^a   Okamoto, Aikou ^b   Chorazy, Mieczyslaw ^a   Czyzewski, Kazimierz ^c   Harasim, Jolanta ^c   Spillare, Elisa A ^b   Hagiwara, Koichi ^b   Hussain, S Perwez ^b   Xiong, Yue ^d   Demetrick, Douglas J ^e   Harris, Curtis C ^b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b NATIONAL CANCER INSTITUTE   (United States)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e Watson School of Biological Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SOMATIC MUTATION;

BASE SEQUENCE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P18; DNA MUTATIONAL ANALYSIS; ENZYME INHIBITORS; GENE DELETION; HETEROZYGOTE; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN KINASE INHIBITORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0029919133     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19960315)65:6<734::aid-ijc4>3.0.co;2-%23     Document Type: Article

References (21)

1. CAIRNS, P., MAO, L., MERLO, A., LEE, D.J., SCHWAB, D., EBY, Y., TOKINO, K., VAN DER RIET, P., BLAUGRUND, J.E. and SIDRANSKY, D., Rates of p16(MTS1) mutations in primary tumors with 9p loss. Science, 265, 415-416 (1994).
2. CALDAS, C, HAHN, S.A., DA COSTA, L.T., REDSTON, M.S., SCHUTTE, M., SEYMUR, A.B., WEINSTEIN, C.L., HRUBAN, R.H., YEO, C.J. and KERN, S.E., Frequent somatic mutations and homozygous deletions of the p16 (MTS-1) gene in pancreatic adenocarcinomas. Nature (Genet.), 8, 27-32 (1994).
3. CHENG, J.Q., JHANWAR, S.C., KLEIN, W.M., BELL, D.W., LEE, W.-C., ALTOMARE, D.A., NOBORI, T., OLOPADE, O.I., BUCKLER, A.J. and TESTA, J.R., p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res., 54, 5547-5551 (1994).
4. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
5. INK4B MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Develop., 8, 2939-2952 (1994).
6. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond.), 371, 257-261 (1994).
7. HAYASHI, N., SUGIMOTO, Y., TSUCHIYA, E , OGAWA, M. and NAKAMURA, Y., Somatic mutations of the MTS-1 (multiple tumor suppressor) 1/CDK41 (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas. Biochem. biophys. Res. Comm., 202, 1426-1430 (1994).
8. HUSSUSSIAN, C.J., STRUEWING, J.P., GOLDSTEIN, A.M., HIGGINS, P.A.T., ALLY, D.S., SHEAHAN, M.D., CLARK, W.H., TUCKER, M.A. and DRACOPOLI, N.C., Germline p16 mutations in familial melanoma. Nature (Genet.), 8, 15-21 (1994).
9. JEN, J., HARPER, J.W., BIGNER, S.H., BIGNER, D.D., PAPADOPOULOS, N., MARKOWITZ, S., WILLSON, J.K.V., KINZLER, K.W. and VOGELSTEIN, B., Deletions of p16 and p15 genes in brain tumors. Cancer Res., 54, 6353-6358 (1994).
10. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVITIGIAN, S.V., STOCKERT, E., DAY, R.S., JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
11. MORI, T., MIURA, K., AOKI, T., NISHIHIRA, T., MORI, S. and NAKAMURA, Y., Frequent somatic mutation of the MTS1/CDK41 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54, 3396-3397 (1994).
12. NOBORI, T., MIURA, K., WU, D.J., LOIS, A., TAKABAYASHI, K. and CARSON, D.A., Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368, 753-756 (1994).
13. INK4 in human cancer. Proc. nat Acad. Sci. (Wash.), 91, 11045-11049 (1994).
14. INK4B/MTS2 and p18 genes in primary and metastatic lung cancer. Cancer Res., 55, 1448-1451 (1995).
15. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning: a laboratory manual (2nd ed.), pp. 9.16-9.19, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989).
16. SERRANO, M., HANNON, G.J. and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366, 704-707 (1993).
17. SHISEKI, M., KOHNO, T., NISHIKAWA, R., SAMESHIMA, Y., MIZOGUCHI, H. and YOKOTA, J., Frequent allelic losses on chromosomes 2q, 18q and 22q in advanced non-small cell lung cancer. Cancer Res., 54, 5643-5648 (1944).
18. TAKESHIMA, Y. and 12 OTHERS, p53 mutations in lung cancers from Japanese mustard gas workers. Carcinogenesis, 15, 2075-2079 (1994).
19. WALKER, D.G., DUAN, W., POPOWIC, E.A., KAYE, A.H., TOMLINSON, F.H. and LAVIN, M., Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res., 55, 20-23 (1995).
20. INK4) in human breast carcinomas. Cancer Res., 54, 5262-5264 (1994).
21. ZHANG, S.-Y., KLEIN-SZANTO, A.J.P., SAUTER, E.R., SHAFARENKO, M., MITSUNAGA, S., NOBORI, T., CARSON, D.A., RIDGE, J.A. and GOODROW, T.L., High frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of head and neck. Cancer Res., 54, 5050-5053 (1994).